[1] Joint United Nations Programme on HIV/AIDS. Global HIV & AIDS statistics — 2020 fact sheet. 2020. https://www.unaids.org/en/resources/fact-sheet. [2020-07-15].https://www.unaids.org/en/resources/fact-sheet
[2] Joint United Nations Programme on HIV/AIDS. 90-90-90 An ambitious treatment target to help end the AIDS epidemic. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS; 2014. https://www.unaids.org/en/resources/documents/2017/90-90-90. [2020-07-15].https://www.unaids.org/en/resources/documents/2017/90-90-90
[3] UNAIDS. Seizing the moment: tackling entrenched inequalities to end epidemics. Geneva, Switzerland; 2020. https://www.philstar.com/opinion/2020/07/09/2026614/seizing-moment-tackling-entrenched-inequalities-end-epidemics. [2020-07-15].https://www.philstar.com/opinion/2020/07/09/2026614/seizing-moment-tackling-entrenched-inequalities-end-epidemics
[4] Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med 2016;375(9):830 − 9. http://dx.doi.org/10.1056/NEJMoa1600693CrossRef
[5] Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365(6):493 − 505. http://dx.doi.org/10.1056/NEJMoa1105243CrossRef
[6] Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, Degen O, et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet 2019;393(10189):2428 − 38. http://dx.doi.org/10.1016/S0140-6736(19)30418-0CrossRef
[7] Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, Van Lunzen J, et al. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA 2016;316(2):171 − 81. http://dx.doi.org/10.1001/jama.2016.5148CrossRef
[8] Bavinton BR, Pinto AN, Phanuphak N, Grinsztejn B, Prestage GP, Zablotska-Manos IB, et al. Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study. Lancet HIV 2018;5(8):e438 − 47. http://dx.doi.org/10.1016/S2352-3018(18)30132-2CrossRef
[9] US Preventive Services Task Force, Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, et al. Preexposure prophylaxis for the prevention of HIV infection: US preventive services task force recommendation statement. JAMA 2019;321(22):2203 − 13. http://dx.doi.org/10.1001/jama.2019.6390CrossRef
[10] Marcus JL, Chao CR, Leyden WA, Xu LF, Quesenberry Jr CP, Klein DB, et al. Narrowing the gap in life expectancy between HIV-infected and HIV-uninfected individuals with access to care. J Acquir Immune Defic Syndr 2016;73(1):39 − 46. http://dx.doi.org/10.1097/QAI.0000000000001014CrossRef
[11] Eisinger RW, Folkers GK, Fauci AS. Ending the human immunodeficiency virus pandemic: optimizing the prevention and treatment toolkits. Clin Infect Dis 2019;69(12):2212 − 7. http://dx.doi.org/10.1093/cid/ciz998CrossRef
[12] PrEP Watch: an AVAC initiative. Global PrEP Tracker 2020. https://www.prepwatch.org/resource/global-prep-tracker/. [2020-07-15].https://www.prepwatch.org/resource/global-prep-tracker/
[13] United Nations General Assembly. Political declaration on HIV and AIDS: on the fast track to accelerating the fight against HIV and to ending the AIDS epidemic by 2030. 2016. https://www.unaids.org/en/resources/documents/2016/2016-political-declaration-HIV-AIDS. [2020-07-15].https://www.unaids.org/en/resources/documents/2016/2016-political-declaration-HIV-AIDS
[14] Hogan AB, Jewell B, Sherrard-Smith E, Vesga J, Watson OJ, Whittaker C, et al. The potential impact of the COVID-19 epidemic on HIV, TB and malaria in low- and middle-income countries 2020. Imperial College London. http://dx.doi.org/10.25561/78670.http://dx.doi.org/10.25561/78670
[15] Centers for Disease Control and Prevention. HIV Surveillance Report: Diagnoses of HIV infection in the United States and dependent areas, 2018 (Updated). 2020. https://www.cdc.gov/hiv/library/reports/hiv-surveillance/vol-31/index.html. [2020-07-15].https://www.cdc.gov/hiv/library/reports/hiv-surveillance/vol-31/index.html
[16] Harris NS, Johnson AS, Huang YA, Kern D, Fulton P, Smith DK, et al. Vital signs: status of human immunodeficiency virus testing, viral suppression, and HIV preexposure prophylaxis — United States, 2013-2018. MMWR Morb Mortal Wkly Rep 2019;68(48):1117 − 23. http://dx.doi.org/10.15585/mmwr.mm6848e1CrossRef
[17] Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV epidemic: a plan for the United States. JAMA 2019;321(9):844 − 5. http://dx.doi.org/10.1001/jama.2019.1343CrossRef
[18] NIH bolsters funding for HIV implementation research in high-burden U.S. Areas. https://www.nih.gov/news-events/news-releases/nih-bolsters-funding-hiv-implementation-research-high-burden-us-areas. [2019-09-5].https://www.nih.gov/news-events/news-releases/nih-bolsters-funding-hiv-implementation-research-high-burden-us-areas